Catalyst Wire Dossier Catalyst Wire Dossier

Interferon α1b inhalation solution

interferon alpha-1b inhalation solution · Kexing Biopharm Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interferon α1b inhalation solution, covering 2024-04-12 to 2024-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections [Phase 3]

See pricing